Antiviral therapy for ocular viral disease

Veterinary Clinics of North America - Small Animal Practice

Volumn 34, Issue 3, 2004, Pages 639-653

  Galle, Laurence E ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ADEFOVIR; ANTIVIRUS AGENT; ARGININE; CIDOFOVIR; DNA POLYMERASE; FOSCARNET; GANCICLOVIR; IDOXURIDINE; INTERFERON; LYSINE; NUCLEOSIDE DERIVATIVE; PENCICLOVIR; RECOMBINANT ALPHA INTERFERON; THIOSEMICARBAZONE DERIVATIVE; THYMIDINE; TRIFLURIDINE; VALACICLOVIR; VIDARABINE; ZIDOVUDINE;

ANIMAL DISEASE; ANTIVIRAL ACTIVITY; BONE MARROW SUPPRESSION; CAT; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; EYE DISEASE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; KIDNEY TUBULE NECROSIS; LIVER NECROSIS; NEPHROTOXICITY; NONHUMAN; POXVIRUS INFECTION; REVIEW; STRUCTURE ANALYSIS; VETERINARY MEDICINE; VIRUS INFECTION;

ADMINISTRATION, TOPICAL; ANIMALS; ANIMALS, DOMESTIC; ANTIVIRAL AGENTS; EYE INFECTIONS, VIRAL; OPHTHALMIC SOLUTIONS;

ANIMALIA; FELIDAE; HUMAN HERPESVIRUS 1;

EID: 1942424859     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2003.12.008     Document Type: Review

References (43)

1. Nasisse M.P. Guy J.S. Davidson M.G. Sussman W.A. Fairley N.M. Experimental ocular herpesvirus infection in the cat. Sites of virus replication, clinical features and effects of corticosteroid administration Invest Ophthalmol Vis Sci 30 8 1989 1758-1768
2. Bodle J.E. Feline herpes virus infection Surv Ophthalmol 21 2 1976 209-225
3. Hartmann K. Donath A. Beer B. Egberink H.F. Horzinek M.C. Lutz H. et al. Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms Vet Immunol Immunopathol 35 1-2 1992 167-175
4. Hartmann K. Ferk G. North T.W. Pedersen N.C. Toxicity associated with high dosage 9-[(2R,5R-2,5-dihydro-5-phosphonomethoxy)-2-furanyl]adenine therapy off attempts to abort early FIV infection Antiviral Res 36 1 1997 11-25
5. Stiles J. Treatment of cats with ocular disease attributable to herpesvirus infection: 17 cases (1983-1993) J Am Vet Med Assoc 207 5 1995 599-603
6. Nasisse M.P. Guy J.S. Davdison M.G. Sussman W. De Clercq E. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine Am J Vet Res 50 1 1989 158-160
7. Bean B. Antiviral therapy: current concepts and practices Clin Microbiol Rev 5 2 1992 146-182
8. Stiles J. Feline herpesvirus Vet Clin North Am Small Anim Pract 30 5 2000 1001-1014
9. Crumpacker C. Antiviral therapy In: Knipe D.M. Howley P.M. Griffin D.E. Lamb R.A. Martin M.A. Roizman R. et al. (Eds.), Field's virology 2001 393-434 Lippincott Williams - Wilkins Philadelphia
10. Derse D. Cheng Y.C. Furman P.A. St Clair M.H. Elion G.B. Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function J Biol Chem 256 22 1981 11447-11451
11. Furman P.A. St Clair M.H. Spector T. Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase J Biol Chem 259 15 1984 9575-9579
12. Flint S.J. Enquist L.W. Krug R.M. Racaniello V.R. Skalka A.M. Prevention and control of virus diseases In: Flint S.J. (Ed.), Principles of virology: molecular biology, pathogenesis, and control vol. 1 2000 662-715 ASM Press Washington, DC
13. Owens J.G. Nasisse M.P. Tadepalli S.M. Dorman D.C. Pharmacokinetics of acyclovir in the cat J Vet Pharmacol Ther 19 1996 488-490
14. Weiss R.C. Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication Am J Vet Res 50 10 1989 1672-1677
15. Naesens L. De Clercq E. Recent developments in herpesvirus therapy Herpes 8 1 2001 12-16
16. Nasisse M.P. Dorman D.C. Jamison K.C. Weigler B.J. Hawkins E.C. Stevens J.B. Effects of valacyclovir in cats infected with feline herpesvirus 1 Am J Vet Res 58 10 1997 1141-1144
17. Prusoff W.H. Mancini W.R. Lin T.S. Lee J.J. Siegel S.A. Otto M.J. Physical and biological consequences of incorporation of antiviral agents into virus DNA Antiviral Res 4 6 1984 303-315
18. Pavan-Langston D. Nelson D.J. Intraocular penetration of trifluridine Am J Ophthalmol 87 6 1979 814-818
19. Teich S.A. Cheung T.W. Friedman A.H. Systemic antiviral drugs used in ophthalmology Surv Ophthalmol 37 1 1992 19-53
20. Maggs DJ, Clarke HE. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus (FHV-1). Am J Vet Res, in press.
21. Gilliam S.E. Field H.J. The effect of (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine (HPMPC) on bovine herpesvirus-1 (BHV-1) infection and reactivation in cattle Antiviral Res 20 1 1993 21-32
22. Romanowski E.G. Bartels S.P. Gordon Y.J. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model Invest Ophthalmol Vis Sci 40 2 1999 378-384
23. De Clercq E. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections Intervirology 40 5-6 1997 295-303
24. Wolf A.M. CVT update: feline leukemia virus In: Bonagura J.D. (Ed.), Kirk's current veterinary therapy 2000 280-284 WB Saunders Philadelphia
25. Levy J.K. CVT update: feline immunodeficiency virus In: Bonagura J.D. (Ed.), Kirk's current veterinary therapy 2000 284-288 WB Saunders Philadelphia
26. Crumpacker C.S. Mechanism of action of foscarnet against viral polymerases Am J Med 92 2A Suppl 1992 3S-7S
27. Griffith R.S. Norins A.L. Kagan C. A multicentered study of lysine therapy in Herpes simplex infection Dermatologica 156 5 1978 257-267
28. Banos G. Daniel P.M. Pratt O.E. Saturation of a shared mechanism which transports L-arginine and L-lysine into the brain of the living rat J Physiol 236 1 1974 29-41
29. Maggs D.J. Collins B.K. Thorne J.G. Nasisse M.P. Effects of L-lysine and L-arginine on in vitro replication of feline herpesvirus type-1 Am J Vet Res 61 12 2000 1474-1478
30. Kadirvel R. Kratzer F.H. Uptake of L-arginine and L-lysine by the small intestine and its influence on arginine-lysine antagonism in chicks J Nutr 104 3 1974 339-343
31. Stiles J. Townsend W.M. Rogers Q.R. Khrone S.G. Effect of oral administration of L-lysine on conjunctivitis caused by feline herpesvirus in cats Am J Vet Res 63 1 2002 99-103
32. Maggs D.J. Nasisse M.P. Kass P.H. Efficacy of oral supplementation with L-lysine in cats latently infected with feline herpesvirus Am J Vet Res 64 1 2003 37-42
33. The basics of immunology: innate immunity (part 1) In: Roitt I.M. Delves P.J. Roitt's essential immunology (Eds.), 10th edition 2001 1-20 Blackwell Science Oxford
34. Biron C.A. Sen G.C. Interferons and other cytokines In: Knipe D.M. Howley P.M. Griffin D.E. Lamb R.A. Martin M.A. Roizman R. et al. (Eds.), Field's virology 2001 321-352 Lippincott Williams - Wilkins Philadelphia
35. Fulton R.W. Burge L.J. Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons Antimicrob Agents Chemother 28 5 1985 698-699
36. Koech D.K. Obel A.O. Efficacy of Kemron (low dose oral natural human interferon alpha) in the management of HIV-1 infection and acquired immune deficiency syndrome (AIDS) East Afr Med J 67 7 Suppl 2 1990 S77-S81
37. Weiss R.C. Cummins J.M. Richards A.B. Low-dose orally administered alpha interferon treatment for feline leukemia virus infection J Am Vet Med Assoc 199 10 1991 1477-1481
38. Nasisse MP, Halenda RM, Luo H. Efficacy of low dose oral, natural human interferon alpha in acute feline herpesvirus-1 (FHV-1) infection: a preliminary dose determination [abstract]. In: Proceedings of the 1996 Annual Meeting of the American College of Veterinary Ophthalmologists. Hawaii, 1996. p. 79.
39. Colin J. Chastel C. Renard G. Cantell K. Combination therapy for dendritic keratitis with human leukocyte interferon and acyclovir Am J Ophthalmol 95 3 1983 346-348
40. de Koning E.W. van Bijsterveld O.P. Cantell K. Combination therapy for dendritic keratitis with human leucocyte interferon and trifluorothymidine Br J Ophthalmol 66 8 1982 509-512
41. de Koning E.W. van Bijsterveld O.P. Cantell K. Combination therapy for dendritic keratitis with acyclovir and alpha-interferon Arch Ophthalmol 101 12 1983 1866-1868
42. Sundmacher R. Mattes A. Neumann-Haefelin D. Adolf G. Kruss B. The potency of interferon-alpha 2 and interferon-gamma in a combination therapy of dendritic keratitis. A controlled clinical study Curr Eye Res 6 1 1987 273-276
43. Sundmacher R. Clinical aspects of herpetic eye diseases Curr Eye Res 6 1 1987 183-188